These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21922135)

  • 1. Clinical significance of UNC5B expression in colorectal cancer.
    Okazaki S; Ishikawa T; Iida S; Ishiguro M; Kobayashi H; Higuchi T; Enomoto M; Mogushi K; Mizushima H; Tanaka H; Uetake H; Sugihara K
    Int J Oncol; 2012 Jan; 40(1):209-16. PubMed ID: 21922135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
    Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
    Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of osteoprotegerin expression in human colorectal cancer.
    Tsukamoto S; Ishikawa T; Iida S; Ishiguro M; Mogushi K; Mizushima H; Uetake H; Tanaka H; Sugihara K
    Clin Cancer Res; 2011 Apr; 17(8):2444-50. PubMed ID: 21270110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of TWEAK expression in colorectal cancer and effect of its inhibition on invasion.
    Lin BR; Huang MT; Chen ST; Jeng YM; Li YJ; Liang JT; Lee PH; Chang KJ; Chang CC
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S385-94. PubMed ID: 21681381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide screening for methylation-silenced genes in colorectal cancer.
    Khamas A; Ishikawa T; Mogushi K; Iida S; Ishiguro M; Tanaka H; Uetake H; Sugihara K
    Int J Oncol; 2012 Aug; 41(2):490-6. PubMed ID: 22664866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
    Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
    J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
    Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
    Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulated GAS1 expression correlates with recurrence in stage II and III colorectal cancer.
    Jiang Z; Xu Y; Cai S
    Hum Pathol; 2011 Mar; 42(3):361-8. PubMed ID: 21111449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EXTL3 promoter methylation down-regulates EXTL3 and heparan sulphate expression in mucinous colorectal cancers.
    Karibe T; Fukui H; Sekikawa A; Shiratori K; Fujimori T
    J Pathol; 2008 Sep; 216(1):32-42. PubMed ID: 18543267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
    Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
    Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases.
    Nagasaka T; Sharp GB; Notohara K; Kambara T; Sasamoto H; Isozaki H; MacPhee DG; Jass JR; Tanaka N; Matsubara N
    Clin Cancer Res; 2003 Nov; 9(14):5306-12. PubMed ID: 14614014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
    Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
    Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of EGFL8: a novel prognostic biomarker for patients with colorectal cancer.
    Wu F; Shirahata A; Sakuraba K; Kitamura Y; Goto T; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2011 Jun; 31(6):2249-54. PubMed ID: 21737648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients.
    Shen YM; Arbman G; Sandström P; Gullstrand P; Wei YQ; Zhang H; Rosell J; Olsson B; Peng F; Yang HS; Wang CT; Sun XF
    Oncol Rep; 2012 Feb; 27(2):376-82. PubMed ID: 22024937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application.
    Ogawa K; Utsunomiya T; Mimori K; Yamashita K; Okamoto M; Tanaka F; Inoue H; Ikeda Y; Saku M; Murayama S; Mori M
    Int J Oncol; 2005 Aug; 27(2):417-26. PubMed ID: 16010423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypomethylation-associated up-regulation of TCF3 expression and recurrence in stage II and III colorectal cancer.
    Li C; Cai S; Wang X; Jiang Z
    PLoS One; 2014; 9(11):e112005. PubMed ID: 25375219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease.
    Ye Q; Wang TF; Peng YF; Xie J; Feng B; Qiu MY; Li LH; Lu AG; Liu BY; Zheng MH
    Oncol Rep; 2010 Feb; 23(2):429-36. PubMed ID: 20043104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPHB4 and survival of colorectal cancer patients.
    Davalos V; Dopeso H; Castaño J; Wilson AJ; Vilardell F; Romero-Gimenez J; Espín E; Armengol M; Capella G; Mariadason JM; Aaltonen LA; Schwartz S; Arango D
    Cancer Res; 2006 Sep; 66(18):8943-8. PubMed ID: 16982731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.